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In Brief
Treger et al. identify Snerv as the genes, encoding Kr€ uppel-associated box zincfinger proteins (KRAB-ZFPs), that underlie the Sgp3 and Gv1 lupussusceptibility loci in mice. SNERV represses expression of non-ecotropic endogenous retroviruses (ERVs). Elevated ERVs in lupus patients correlate with KRAB-ZFP down-regulation, suggesting a central role for dysfunctional ERV regulation in human lupus.
INTRODUCTION
Retroelements (REs) are mobile DNA species that compose $40% of murine and human genomes (Lander et al., 2001; Waterston et al., 2002) . Although generally silenced, these elements can cause insertional mutagenesis and have diverse effects upon gene expression (Goodier, 2016) . The ability to limit RE movement in the genome is fundamentally important because transposon-mediated disruption or dysregulation of genes contributes to more than 100 human diseases, including hemophilia and leukemia (Goodier, 2016; Hancks and Kazazian, 2016; Kazazian and Moran, 2017) . Endogenous retroviruses (ERVs) are REs formed by the remnants of past retroviral infection that have accumulated in the genome over millennia. Many ERVs retain transposition potential and are responsible for $10% of spontaneous mutations in inbred mice (Kazazian and Moran, 1998; Maksakova et al., 2006) . More recently acquired ERVs have retained envelope-coding regions in addition to structural genes that encode the gag matrix, protease, and polymerase (Kozak, 2014) . These proviral ERVs are located throughout the genomes of inbred mouse strains (Coffin et al., 1989) .
As with exogenous retroviruses, infectious ERVs, originally identified in constitutively viremic mouse strains, are appreciated for their role in malignant transformation (Kassiotis, 2014; Kozak, 2014) . Additionally, in certain immune-deficient murine backgrounds and cancer-cell lines, ERV transcripts from mousetropic (i.e., ecotropic) and non-ecotropic ERV (NEERV) loci recombine to generate infectious ERVs (Ottina et al., 2018; Young et al., 2012; Yu et al., 2012) . Thus, transcriptional silencing of genomic ERV sequences is a critical layer of defense from active retrotransposition, restoration of infectivity, and insertional mutagenesis leading to oncogenesis. RE loci are targeted by epigenetic modifications that result in establishment and maintenance of transcriptional repression (Macfarlan et al., 2011; Matsui et al., 2010; Rowe et al., 2013b; Wolf and Goff, 2007) . This transcriptional silencing is generally initiated by Kr€ uppel-associated box-domain zinc-finger proteins (KRAB-ZFPs), a large family of DNA-binding transcriptional regulators in vertebrates (Ecco et al., 2017) . KRAB-ZFPs can recognize and bind to DNA sequences common in RE families through their C-terminal zinc fingers and recruit KRAB-associated protein 1 (KAP1) through the N-terminal KRAB domain to form a scaffold around which transcriptional silencing machinery can assemble (Ecco et al., 2017; Rowe et al., 2013a; Rowe et al., 2010) . ZFP809 binds to and silences ecotropic ERV loci in this manner (Wolf and Goff, 2009; Wolf et al., 2015) . However, a specific KRAB-ZFP repressor responsible for silencing NEERV transcripts in mice has not yet been identified.
The role of ERV dysregulation in the pathogenesis of autoimmune disease is implicated but not established. Elevated transcription of human ERV (HERV) loci and antibody reactivity to HERV proteins occurs in many autoimmune diseases (Grandi and Tramontano, 2018; Grö ger and Cynis, 2018) . In systemic lupus erythematosus (SLE) patients, hypomethylation of HERV loci and antibody reactivity to HERV and retroviral (HIV-1 and HTLV-1) proteins are implicated in SLE pathogenesis (Blomberg et al., 1994; Hishikawa et al., 1997; Mellors and Mellors, 1976; Nakkuntod et al., 2013; Perl et al., 1995; Wu et al., 2015) . This association between HERV dysregulation and SLE pathogenesis is further strengthened by murine models of spontaneous lupus, in which NEERV envelope glycoprotein gp70 is a major autoantigen promoting lupus nephritis (Baudino et al., 2008; Ito et al., 2013; Yoshiki et al., 1974) . Yet the association between HERV dysregulation and SLE remains tentative: HERVs are poorly annotated in the genome and knowledge about HERV transcriptomes is limited; specific factors that modulate HERV expression in SLE patients have not been identified; and molecular mechanisms linking HERV dysregulation to SLE pathogenesis have not been defined (Nelson et al., 2014) . Even in murine lupus models, the gene and mechanism responsible for NEERV dysregulation is not known. The Gross virus antigen 1 (Gv1) locus in 129 strains and the serum gp70 production 3 (Sgp3) locus in lupus-prone New Zealand Black (NZB) and New Zealand White (NZW) strains both drive elevated NEERV expression, a major hallmark of disease (Andrews et al., 1978; Baudino et al., 2008; Izui et al., 1979) . Although the Sgp3 and Gv1 loci have been mapped by QTL analyses to an interval on chr13 (Laporte et al., 2003; Oliver and Stoye, 1999) , the identity of the gene(s) responsible for the gp70 overexpression remains unknown.
In this study, we identified the KRAB-ZFP genes within the Sgp3 and Gv1 loci that are responsible for silencing of NEERV transcripts. We also examined HERV mRNA expression in the peripheral blood mononuclear cells of SLE patients and found putative HERV-suppressing KRAB-ZFP genes whose expression inversely correlated to that of HERV. Our findings suggest that a similar defect in HERV repression may promote human lupus pathogenesis.
RESULTS

NEERV Transcription Is Globally Increased in C57BL/6N but Not in C57BL/6J Mice
In experiments to test innate viral sensors involved in control of ERVs, we found that steady-state lymphocyte NEERV envelope mRNA and protein expression from xenotropic (Xmv) and polytropic (Pmv) loci differed by background substrains: NEERV expression was increased in C57BL/6N (B6N) compared to expression in C57BL/6J (B6J) (Figures 1A and 1B) . These substrains were separated only $70 years ago, and a number of SNPs differentiate these substrains (Mekada et al., 2009; Simon et al., 2013) . To identify B6N and B6J transcriptome differences, we carried out RNA sequencing in naive CD4 + (cluster of differentiation 4 + ) T cells. To map sequencing reads to unique proviral ERV loci, we developed an analysis pipeline in which we used a list of proviral ERV loci obtained from Jern et al. (2007) in combination with an algorithm composed of stringent filtering criteria adapted from Schmitt et al. (2013) . The major transcriptional difference between B6N and B6J mice was a global increase in B6N Xmv, Pmv, and modified polytropic (Mpmv) NEERV transcripts, with minimal impact on the ecotropic ERV, Emv2, or on other cellular genes ( Figure 1C ). NEERV transcription was increased regardless of whether reads were mapped to unique NEERV loci ( Figure 1C ) or to NEERV long terminal repeat (LTR) families ( Figure 1E ). This phenotype was penetrant across various cell types, including lymphocytes, total bone marrow, bone-marrow-derived macrophages (BMDMs), and embryonic stem cells (Figures S1A and S1B) . Indeed, all uniquely mappable NEERV loci and NEERV LTR families were also increased in RNA sequencing of B6N BMDMs compared to that of B6J BMDMs ( Figures 1D and 1F) . Across cell types, increased B6N NEERV expression was also highly specific to this RE family; by mapping to unique loci or entire repeat families, the expression of long interspersed nuclear element 1 (LINE1) and other LTR families by RT-qPCR (reverse transcription quantitative polymerase chain reaction) or RNA sequencing was unchanged in either naive CD4 T cells or BMDMs ( Figures 1B, 1C , 1E, S1C, and S1D). Thus, B6N mice expressed elevated levels of NEERV mRNA and envelope proteins compared to B6J mice.
Intergenic NEERV Loci Are Enriched for Activating Histone Modifications and Depleted of Repressive Histone Modifications in B6N Bone-Marrow-Derived Macrophages Although actively transcribed regions are enriched for histone modifications, including histone 3 lysine 4 trimethylation (H3K4me3) and H3K27 acetylation (H3K27Ac), REs are generally enriched for the repressive histone mark H3K9me3 (Groh and Schotta, 2017) . To investigate if epigenetic silencing is perturbed at B6N NEERV loci, we performed chromatin immunoprecipitation and sequencing (ChIP-seq) of B6N and B6J BMDMs for active and repressive histone marks. We mapped ChIP-seq reads to unique NEERV loci (Jern et al., 2007) , including sequences upstream and downstream of NEERV provial genomes. To avoid confounding regulation of NEERV elements with regulation of genes within which they reside, we excluded 19 non-intergenic NEERV loci from analysis. We additionally mapped the ChIP-seq reads to all 71 intergenic loci that encode unique full-length viral-like 30 (VL30) elements (Markopoulos et al., 2016) . VL30s are retrovirus-like LTR REs that contain gag matrix and integrase and polymerase coding regions but lack intact open reading frames. Although they share many of the same structural elements as NEERV and are actively transcribed, VL30 mRNA were not differentially expressed between B6N and B6J mice ( Figures S1C and S1D ). Unlike B6N VL30 loci, intergenic B6N NEERV loci were significantly enriched for H3K4me3 and H3K27Ac (Figures 2A and 2B ), whether mapping reads to the full-length (Figure 2A , top row) or to the first 2 kilobases (kb) (Figure 2A , middle row) of the RE loci. Concordantly, B6N NEERV, and not VL30, loci were significantly depleted of H3K9me3, regardless of whether reads were mapped to the full-length or to the first 2 kb of the RE loci. There were no differences between activating marks and repressive marks in the region immediately upstream (1 kb) of the B6N NEERV ( Figure 2A , bottom row). These data revealed that intergenic B6N NEERV loci possessed significantly increased activating and significantly reduced repressive histone modifications, suggesting that activation of B6N NEERV transcription occurs secondary to a primary failure of epigenetic silencing.
Recessive Loss of Proviral Endogenous Retrovirus Silencing Maps to a 1 Mb Deletion on Chromosome 13
We next investigated the heredity of this phenotype by crossing B6N with B6J mice and evaluating the isogenic F1 generation. C57BL/6NJ F1 CD4 T lymphocytes expressed low NEERV envelope protein and mRNA levels ( Figure 3A) , demonstrating that the B6N phenotype of enhanced NEERV expression was recessive. Consistent with our ChIP-seq data, this suggested the existence of a NEERV repressor in B6J mice that is absent in B6N mice. To identify the genomic location that associates with the B6N phenotype, we performed a quantitative trait locus (QTL) analysis on 46 mice from the F2 C57BL/6NJ intercross. The mice were phenotyped for 5 parameters: surface ERV envelope expression on B, CD4 T, and CD8 T cells and total splenocyte Xmv and Pmv envelope mRNA expression ( Figures S2A and S2C ). Mice were genotyped at 150 SNPs that differentiate B6N and B6J substrains. We identified a single QTL locus on chromosome 13 that was significant for all 5 phenotypes ( Figure 3B ) and investigated nucleotide and structural variation across the -log 10 (padj)
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Adjusted p values in Figure 1 and Figure S1 were calculated for multiple t tests (two-tailed) comparing B6N to B6J for each gene, corrected for the 25 independent hypotheses tested in Figure 1 and Figure S1 using the HolmSidá k method with an alpha value of 0.05 for the entire family of comparisons. Adjusted p values in (D) and (E) were calculated with DESeq2. See also Figure S1 . predicted QTL interval from whole genome sequencing (WGS) data of B6N and B6J genomes (Figures S2D and S2F) . In addition to identifying known (Simon et al., 2013) non-synonymous coding SNPs ( Figure S2E ), copy number variant analyses ( Figures 3C, S2F , and S2G) supported by TaqMan Copy Number qPCR assays ( Figure 3D ) revealed a $1 Mb deletion within the QTL locus unique to the B6N genome ( Figure 3E ). No other structural variants were identified in the B6N genome that were not also present in the B6J genome. These findings indicated that loss of NEERV repression has occurred in the B6N substrain secondary to a deletion on chromosome 13.
Homozygous 2410141K09Rik
-/-Gm10324 -/-Mice Fail to
Repress NEERV mRNA and Protein Expression Within this deleted region of chromosome 13, there are 2 annotated coding genes, 2410141K09Rik and Gm10324, both of which are KRAB-ZFPs; 4 non-coding RNAs; and 3 pseudogenes ( Figure 3E ). To determine the gene(s) responsible for NEERV repression, we generated B6J mice deficient in one or multiple genes within the chromosome 13 region of interest by using CRISPR technology ( Figures 4A and S3A ). Due to the extremely repetitive nature of this chromosomal region, individual guide RNAs targeted multiple cut sites. Traditional PCR genotyping and sequencing was insufficient to confirm genetic deletions. . This corresponds to: summation of the normalized ChIP-seq read counts across the full length (top row), first 2 kb (middle row), or 1 kb immediately upstream (bottom row) of the NEERV (red) or VL30 (gray) loci for the histone modifications or input in B6N or B6J samples; addition of a pseudocount of 0.1 to all totals to avoid division by zero; division of the sums of the histone modifications by the sums of the input for the respective strain; and finally, division of the B6N-based value by the B6J-based value.
(B) Normalized fold changes plotted for each histone modification, with respect to each analyzed region as described above. Mean and standard deviation are plotted in black.
Adjusted p values were calculated for multiple t tests comparing NEERV to VL30 for each histone mark across each region, corrected for the 9 independent hypotheses tested with the HolmSidá k method with an alpha value of 0.05 for the entire family of comparisons.
Thus, we additionally used TaqMan probe amplification loss (Figure 4B) and whole genome 103 sequencing (Figures S3B and S3C) . Of the 4 CRISPR-generated strains lacking portions of chromosome 13, only mice with a homozygous deletion of both 2410141K09Rik and Gm10324 (241Rik À/À Gm10324 À/À ) were unable to repress NEERV by RT-qPCR ( Figure 4C ). By RNA sequencing ( Figure 4D ), 241Rik À/À Gm10324 À/À phenocopied B6N mice, with concordance in both expression of the NEERV loci and an increase of the magnitude of expression. This was also reflected in the levels of surface-ERV envelope-protein expression on lymphocytes ( Figure 4E ). Mice with a heterozygous deletion of these genes (241Rik
) maintained B6J NEERV expression levels, confirming the haplosufficient nature of 241Rik and Gm10324 activity demonstrated by the C57BL/6NJ F1 mice ( Figure 3A) . Additionally, expression of non-NEERV RE was not increased ( Figure S3D ), validating the specificity for NEERV repression that was lost in the 241Rik
mice. The expression of 8 cellular genes was also significantly increased more than 2-fold in the 241Rik
T cells ( Figure 4D ). Six of these genes directly overlap a NEERV LTR, suggesting that their increased expression may have resulted from a failure to silence the internal NEERV element. For example, Camk2b encodes for a neuronal protein kinase whose third intron contains an RLTR4_MM NEERV element. Cam2kb was one of the most significantly increased genes in both B6N and 241Rik
NEERV dysregulation, rather than substrain nucleotide differences (Simon et al., 2013) , might have mediated this effect. Thus, the 241Rik
Gm10324
À/À phenotype indicated that one or both of these genes were responsible for silencing NEERV in the B6 genome and implicated NEERV dysregulation in increasing the expression of nearby cellular genes. We have therefore named 2410141K09Rik and Gm10324 suppressor of NEERV (Snerv) 1 and 2 (Snerv1 and Snerv2), respectively. The locus on chromosome 13 that contains Snerv1 and Snerv2 is remarkable for its extremely repetitive nature, which (E) The deleted region in the B6N genome spans several long intergenic non-coding RNAs and pseudogenes and 2 Kr€ uppel-associated box zinc-finger proteins. p values in (A) were calculated using one-way ANOVA with Sidá k's multiple comparisons test and an alpha value of 0.05. QTL p values were calculated by performing 10,000 permutation tests to obtain a genome-wide distribution for the null hypothesis. See also Figure S2 . necessitated WGS over PCR-based approaches for genotyping. Indeed, even stringent mapping criteria of commonly used sequencing alignment programs erroneously mapped a high proportion of low-confidence paired-end 150 bp reads into this interval from genomes (such as B6N) in which this region was absent and therefore could not contribute reads ( Figures S4A-S4C ). Thus, alignments to and read counts for these genes using short-read sequencing technologies were not reliable. It is also of note that Snerv1 and Snerv2 were only expressed in early development ( Figures S4C-S4E ), preventing the detection of differential gene expression in somatic tissues. 
-/-Mice Fail to Repress NEERV mRNA and Protein Expression (A) Schematic of chromosome 13 regions that were deleted in two of the B6J CRISPR-generated mice that were sequenced. (B) TaqMan probes with unique binding sites in the region of interest were used to amplify product from NZB, 129S1, B6N, B6J, and the CRISPR-generated mice (n = 5 per group).
(C) RT-qPCR of RNA from peripheral blood of wild-type (WT) and CRISPR-generated mice (n = 5-18 per group) for Xmv, Pmv, and Mpmv envelope mRNA. Values were normalized to GAPDH expression. Listed are the significant adjusted p values for multiple t tests comparing all genotypes to the B6J WT littermate value for each gene, corrected for the 33 independent hypotheses tested in Figure 4 using the HolmSidá k method with an alpha value of 0.05 for the entire family of comparisons. (D) Volcano plot of differentially expressed cellular genes and all 47 uniquely mappable ERV loci from mRNA sequencing of B6J and 241Rik 
2017). Our Snerv1/Snerv2
À/À phenotype suggested that one or both of these genes encode the KRAB-ZFP responsible for repression of NEERV. To determine if either of these proteins could interact with KAP1, because of the high homology to additional KRAB-ZFP loci and non-unique flanking sequences, both genes had to be codon-optimized and synthesized de novo. FLAG-tagged SNERV1 or SNERV2 were transiently overexpressed in HEK 293T cells to test the ability to immunoprecipitate with KAP1. FLAG-ZFP809 served as a positive control for KAP1 binding. Although both proteins were expressed to similar levels in nuclear extract, only FLAG-SNERV1, not FLAG-SNERV2, strongly bound to KAP1 ( Figure 5A ). The 5 0 LTRs of NEERV loci contain a GC-rich primer binding site (PBS) ( Figure 5B) that is complementary to the 3 0 end of cellular tRNAs and primes reverse transcription (Gilboa et al., 1979) . ZFP809 binds to a proline-complementary PBS (PBS Pro ) sequence, recruits KAP1, and represses ecotropic ERV transcription ( Figure 5A ) (Wolf and Goff, 2009 Pmv15 is a PBS Gln -encoding NEERV whose expression is strongly repressed in B6J and highly increased in B6N CD4 T cells (Fig 1C) . We generated 32 bp DNA oligonucleotides spanning the Pmv15 PBS sequence and the immediate downstream bases that improve binding of ZFP809 to its target PBS (Kempler et al., 1993) . We also designed 54-59 bp oligonucleotides that additionally include sequences from the upstream LTR. These Pmv15-based oligonucleotides were also modified to alternatively encode PBS Pro , PBS Thr , or PBS Gln sequences (Fig- ure 5B). We next produced purified recombinant GST-FLAGtagged SNERV1 and SNERV2 proteins ( Figure S5A ) and performed DNA pull-down and electrophoretic mobility shift assays (EMSAs) to test the ability of SNERV1 and SNERV2 to bind these oligonucleotides. Recombinant SNERV1 strongly bound to the PBS Gln oligonucleotide by DNA pull-down ( Figure 5C ), and this (E) EMSA of 54 bp AlexaFluor488-labeled double-stranded LTR oligonucleotides (AF488-PBS) using no protein or 10 mg of recombinant GST-FLAG-SNERV1 or GST-FLAG-SNERV2.
(F) EMSA of 54 bp AF488-PBS-Q using increasing amounts of recombinant GST-FLAG-SNERV1 or GST-FLAG-SNERV2.
Competitor 59 bp unlabeled PBS-Q and PBS-Q 0 LTR oligonucleotides were used in lanes 5-6 and 10-11 in (F) in 10-fold excess. See also Figure S5 . Figure 5E ), which was competitively reduced upon the addition of excess unlabeled PBS Gln oligonucleotide ( Figure 5F ). However, SNERV1 binding to the PBS Gln probe was not competitively reduced by excess unlabeled PBS Gln oligonucleotide lacking the downstream 13 bp motif (Figure 5F ), providing further evidence that the PBS Gln sequence and downstream motif were both required for specific binding of SNERV1 to the NEERV LTR. Accordingly, the presence of PBS Gln was not sufficient for transcriptional repression because the 10 intergenic VL30 loci that possess PBS Gln were not differentially expressed upon loss of Snerv1 and Snerv2 ( Figures S1C, S1D , and S5B). Additionally, these same loci were not enriched for H3K4me3 or H3K27Ac or depleted of H3K9me3 ( Figure S5C ). The 13 bp sequence downstream of PBS Gln VL30 differed at many residues from that found in the NEERV LTR (Table S1 ). Together, these data suggested that sequences within the NEERV LTR, in addition to PBS Gln , are required for specificity. Although recombinant SNERV2 bound weakly to these oligonucleotides, SNERV2 was nevertheless similarly selective for the PBS Gln sequence and the requirement for the downstream motif ( Figures 5E and 5F ). Snerv1 and Snerv2 both encode a KRAB-A box and 14 or 19 zinc fingers, respectively. The 5 additional canonical zinc fingers of SNERV2 correspond to 140 amino acids, which produced 2 gaps in global pairwise alignment with SNERV1 ( Figure S5D ). However, the aligned amino acids of SNERV1 and SNERV2 shared 87% (404/464) identity and 93% (429/464) conservation. Given their genomic proximity and high degree of homology, Snerv1 and Snerv2 may have arisen through tandem duplication, thereby providing for inherent shared specificity for NEERV LTR PBS Gln . Collectively, although both proteins were selective for the PBS Gln sequence in the NEERV LTR, only SNERV1 was capable of both stronger binding to the PBS Gln sequence and better recruitment of KAP1.
The NZB and 129 Genomes Fail to Complement NEERV Derepression in the Snerv1/Snerv2 -/-Genome Next, we examined the physiological relevance of SNERV loss in NEERV repression. NEERV expression is highly increased in NZB, NZW, and 129 strains and associates with lupus nephritis (Andrews et al., 1978; Baudino et al., 2008; Ito et al., 2013; Izui et al., 1979; Yoshiki et al., 1974) . The Sgp3 locus in NZB and NZW strains and the Gv1 locus in 129 strains drive increased NEERV expression and are mapped by QTL analyses to similar large intervals on chromosome 13 that both include Snerv1 and Snerv2 (Laporte et al., 2003; Oliver and Stoye, 1999) . Loss of TaqMan probe amplification in proximity to both Snerv genes from NZB and 129 genomic DNA ( Figure 4B ) suggested that this interval might also be deleted in the NZB and 129 strains. Alignment quality of next-generation sequencing short reads across this chromosome 13 region from NZB and 129 genomes was extremely poor, exemplified by erratic read depth and copynumber calls by both Sequenza and CNVnator ( Figures S2F  and S2G ). We were unable to further clarify the structure of this region in the NZB genome with 103 WGS (Figures S6A and  S6D) mice both demonstrated that heterozygosity of these genes conferred haplosufficiency for NEERV repression. Therefore, if the Sgp3 and Gv1 loci do not involve these KRAB-ZFP genes, then both the NZB and 129 genomes will possess intact copies of these genes and will complement the Snerv1/Snerv2
À/À genome to restore NEERV repression to levels exhibited by the B6J-NZB F1 cross. Although NZB and B6J mice possess many of the same Mpmv and Pmv loci, only 5 Xmv loci are shared (Frankel et al., 1992; Kihara et al., 2011) . Additionally, NZB mice express high levels of Xmv mRNA from both constitutive and inducible Xmv loci (Elder et al., 1980) . Unlike B6J mice, which predominantly express Xmv9, Xmv10, Xmv13, Xmv14 (all PBS Gln ), and Xmv43 (PBS Pro ) ( Figures 1B and 1D ), the highly expressed NZB Xmv NEERV encode PBS Pro (Baudino et al., 2008; O'Neill et al., 1985) . Xmv loci can be further subdivided into 4 subgroups, Xmv-I through Xmv-IV, whose transcripts can be amplified with subgroup-specific envelope primers. All B6 Xmv elements utilizing PBS Pro belong to Xmv-I or Xmv-IV subgroups (Table S1) , and the strongly expressed constitutive and inducible NZB Xmv loci are classified as Xmv-I (Baudino et al., 2008; Kihara et al., 2011) . These PBS Pro -encoding Xmv-I and Xmv-IV elements should not be subject to SNERV-mediated repression, which is specific to PBS Gln . Compared to B6J3NZB F1 pups, Snerv1/Snerv2 À/À 3NZB F1 pups expressed significantly higher levels of NEERV envelope protein on the surface of peripheral blood B cells, CD4 T cells, and CD8 T cells ( Figure 6A ). The expression of Xmv, Pmv, and Mpmv envelope mRNA was likewise significantly elevated in peripheral blood from these same mice compared to B6J3NZB F1 controls ( Figure 6B ). Xmv-I expression was highly driven in both crosses, likely a consequence of the known constitutive PBS Pro Xmv-I transcription that is characteristic of NZB mice. As expected, the expression of Xmv-I and Xmv-IV mRNA did not differ between the two crosses ( Figure 6C ). However, in contrast to their SNERV haplosufficient counterparts, Snerv1/ Snerv2 À/À 3NZB F1 pups were unable to repress NEERV expression from PBS Gln -encoding Xmv-II and Xmv-III loci, leading to highly increased transcription from these loci ( Figure 6C ). These data indicated that SNERV proteins are required for B6J mice to repress Xmv, Pmv, and Mpmv loci in B6J3NZB F1 mice.
Compared to B6J mice, 129 mice possess few Xmv loci and express near-undetectable levels of Xmv envelope transcripts (Baudino et al., 2008; O'Neill et al., 1986; Yoshinobu et al., 2009 ). As such, Xmv transcription in the B6J3129 and Snerv1/ Snerv2 À/À 3129 F1 crosses arises largely from B6J loci. The Gv1 locus controls Pmv, but not Mpmv, transcription in 129 mice (Oliver and Stoye, 1999) . Compared to SNERV haplosufficient B6J3129 F1 pups, the Snerv1/Snerv2 À/À 3129 F1 pups expressed significantly higher levels of NEERV envelope protein on the surface of peripheral B cells and CD4 T cells ( Figure 6D ). Accordingly, Xmv and Pmv NEERV envelope mRNA was significantly increased in peripheral blood from these same mice compared to that of B6J3129 F1 controls ( Figure 6E ). As in Snerv1/Snerv2 À/À 3NZB mice, PBS Gln -encoding Xmv-II and Xmv-III envelope mRNA expression was significantly increased in Snerv1/Snerv2 À/À 3129 mice ( Figure 6F ). Xmv-I transcription in Snerv1/Snerv2 À/À 3129 F1 mice, which lack the high PBS Pro Xmv-I expression of the NZB-based crosses that would otherwise mask its detection by RT-qPCR, was also significantly increased.
From the patterns of NEERV expression observed in the two sets of crosses, it is evident that control of NEERV expression is multifactorial, based on strain-specific locations and sequences of proviral NEERV; cell-type-specific transcriptional programs that dictate which NEERV loci are in euchromatin; and strain-and cell-specific factors that regulate NEERV mRNA and protein synthesis and degradation. Yet unlike B6J3NZB and B6J3129 F1 mice, both Snerv1/Snerv2
3129 F1 mice were unable to repress NEERV. These data demonstrated that functional SNERVs are absent in both NZB and 129 genomes. Although we could not rule out an effect from nearby intergenic deletions that are also present in the Snerv1/Snerv2 À/À genome ( Figure 4A ), two similar non-coding deletions, including that in the Platr2 pseudogene, were present in the A À/À genome and did not give rise to increased NEERV expression. This suggested that such noncoding deletions do not impact the function of Snerv1 or Snerv2 or otherwise modulate expression of NEERV. Thus, the failure of the NZB and 129 genomes to complement the loss of these genes implicates defective SNERV at both the Sgp3 and Gv1 loci.
Human ERV LTR Elements Are Elevated in the Blood of Patients with SLE and Anticorrelate with Three KRAB-ZFPs Our data support a role for KRAB-ZFP-mediated loss of NEERV suppression in murine lupus pathogenesis. To investigate the relevance of these findings to human SLE, we interrogated publicly available RNA-seq data of whole blood from SLE patients and healthy controls (Hung et al., 2015; Kalunian et al., 2016) for HERV expression, using the RepEnrich algorithm to quantitate read counts for HERV LTR families and subfamilies. A number of LTR subfamilies were significantly elevated in SLE blood compared with that of healthy controls ( Figure 7A ). Although some SLE patients expressed low levels of ERVs comparable to those of healthy controls, the majority of SLE patients expressed elevated levels of all LTR subfamilies compared with those of healthy controls ( Figure 7B ). SLE patients expressed elevated levels of ERVL-MaLR (mammalian apparent LTR retrotransposon), ERV1, and ERVL, which represent class I gammaretroviruses (ERV1) and class III spuma-like retroviruses (ERVL-MaLR and ERVL) ( Figure 7C ).
In an effort to identify potential KRAB-ZFPs that could function as suppressors of HERV, which may be dysfunctional in SLE patients, we performed a Spearman correlation analysis between the 38 KRAB-ZFP genes that were significantly repressed in SLE patients ( Figure S7A ) and the sum of RepEnrich scores for ERVL-MaLR, ERV1, and ERVL families. Three KRAB-ZFPs-ZNF777, ZNF579, and ZNF212 ( Figure 7D )-were significantly negatively correlated with all 3 LTR families. When expression of these KRAB-ZFPs was correlated with the expression of all RNA sequencing data from whole blood of SLE patients (n = 99) and healthy controls (n = 18) were used to perform RepEnrich and DESeq2 analyses to quantify expression of LTR elements and cellular genes, respectively. (A) Volcano plot of significantly elevated LTR subfamilies in the blood of SLE patients versus healthy controls. LTR subfamilies indicated in red are log 2 (fold change) > 1 and p adj < 0.05 in SLE patients versus healthy controls. (B) Heatmap of all LTR subfamilies that are significantly differentially expressed in SLE patients compared with healthy controls (p adj < 0.05, n = 316). Hierarchical clustering of patients was performed based on Euclidean distance. (C) The sum of all reads that belong to each indicated LTR family was graphed per individual. Two-way ANOVA was performed to calculate statistical significance. ****p < 0.0001; ns, not significant. (D and E) Spearman correlation was calculated between all of the repressed KRAB-ZFPs and the sum of RepEnrich scores for the significantly elevated LTR families (D), and LTR subfamilies that belong to the ERVL-MaLR, ZNF777, ZNF212, and ZNF579 (E) among SLE patients. The correlation plot represents Spearman r values and displays only correlations that were p < 0.05. Blank indicates not significant. See also Figure S7 . of the LTR subfamilies within each of the LTR families, these KRAB-ZFPs and most of the HERV subfamilies were consistently and significantly negatively correlated ( Figures 7E, S7B , and S7C). Thus, analogous to SNERV, these KRAB-ZFPs may function as suppressors of HERV, and decreased expression of these KRAB-ZFPs in SLE patients may contribute to the elevated HERV expression that was observed.
DISCUSSION
Our study identified Snerv1 and Snerv2, encoding KRAB-ZFPs responsible for NEERV repression in multiple inbred mouse strains. SNERV targeted the PBS Gln sequence within the NEERV LTR and recruited the KAP1 protein to promote formation of heterochromatin at NEERV loci. Germline homozygous deletion of two KRAB-ZFPs, Snerv1 and Snerv2, increased activating chromatin modifications, transcription, and expression of proteins from NEERV loci. F1 crosses of lupus-prone NZB and 129 mice to Snerv1/Snerv2 À/À mice were unable to rescue defective NEERV repression, thus mapping the lupus-associated Sgp3 and Gv1 loci to Snerv1 and Snerv2 and demonstrating that loss of SNERV drove overexpression of the lupus autoantigen gp70. Similar to the way in which SNERV loss and resultant NEERV dysregulation are a hallmark of spontaneous lupus disease in mice, global increases in HERV family and subfamily expression were a salient transcriptional feature of SLE disease in humans. Antibodies against specific HERV antigens are present in SLE patients (Bengtsson et al., 1996; Blomberg et al., 1994; Nelson et al., 2014; Perl et al., 1995 ), yet it is not known how HERV-antigen overproduction results in this loss of tolerance. Having identified SNERV as the KRAB-ZFP targeting NEERV in lupus-prone NZB and 129 mice, it will now be possible to define the contribution of ERV to lupus nephritis pathogenesis and test how ERV mis-regulation mediates loss of tolerance in murine and human lupus disease. Restoration of SNERV1 and SNERV2 to the germline represses NEERV loci and prevents gp70 overproduction in lupus-prone mice. Generation of Snerv1/Snerv2-competent NZB and NZW will permit targeted approaches to manipulate the gp70 phenotype in vivo and can be used to conclusively test the requirement for dysregulated NEERV in the pathogenesis of lupus. Although Snerv1 and Snerv2 are in epistasis with additional susceptibility loci that enhance disease in models of spontaneous lupus (Celhar and Fairhurst, 2017; Crampton et al., 2014; Morel, 2010) , such experiments will elucidate the connection between ERV mis-regulation and lupus pathogenesis. Using Snerv1/Snerv2-competent lupus-prone mice, it will be possible to rigorously test how tolerance is lost in the setting of high NEERV autoantigen production, how anti-NEERV autoantibodies are induced, and how NEERV dysregulation itself contributes to lupus severity. Establishing the precise role of NEERV autoantigen overexpression in murine nephritis will likewise contribute to our general understanding of how loss of tolerance and autoantibody production occur in autoimmunity.
NZB-and NZW-based lupus models are widely used in pre-clinical drug-efficacy trials because they recapitulate more clinical features of human SLE than other mouse strains (Celhar and Fairhurst, 2017; Li et al., 2017) . Of the few drugs approved for treatment of SLE by the FDA, essentially all-systemic immunosuppressants, antimalarials, anti-BAFF, anti-CD20, anti-CTLA-4, interferon-alpha blockade, and toll-like receptor antagonists-were tested pre-clinically in NZB/W models (Celhar and Fairhurst, 2017) . Clarifying the role of NEERV in disease progression will shape how pre-clinical testing for lupus nephritis proceeds and whether it may be feasible to pursue the development of therapeutics that target ERVs. In these ways, our identification of Snerv1 and Snerv2 and the mechanism of NEERV repression has many applications to the study of both human lupus pathogenesis and treatment.
KRAB-ZFPs that target REs tend to emerge following genomic invasion by the retrovirus that they target. Although KRAB-ZFPs are broadly conserved in mammals, a large subset of rodent KRAB-ZFPs are specific to the order Rodentia . With full-length retrovirus architecture and intact open reading frames, NEERVs are among the more recently endogenized murine REs (Tomonaga and Coffin, 1998) . Although Snerv1 and Snerv2 have orthologs in the rat and hamster genomes, none are found in the human genome. We therefore posit that these genes emerged in the last common ancestor of mice, rats, and hamsters shortly following the invasion of its genome by the MLV-type retrovirus that it targets. Yet just as the presence of a PBS is conserved across retroelements, PBS targeting is highly conserved across different KRAB-ZFPs, regardless of their target species (Ecco et al., 2016; Wolf and Goff, 2007; Wolf et al., 2008) . This suggests that the mechanism of PBS Gln targeting may very well be conserved in a different human KRAB-ZFP and HERV pairing. Three human KRAB-ZFPs were identified whose expression was significantly repressed in SLE patients and whose levels were significantly anticorrelated with increased HERV expression in SLE patients. Although our current study does not provide functional evidence, investigating polymorphisms in and near these 3 KRAB-ZFP genes, and epigenetic regulation of these KRAB-ZFPs in SLE and healthy cohorts could prove informative. Thus, with broad implications for human SLE and autoimmunity, identification of Snerv1 and Snerv2 and their mechanism of NEERV repression will permit interrogation of the association between NEERV overexpression and murine lupus pathogenesis. Our finding that Snerv1 and Snerv2 underlie the lupus-associated Sgp3 and Gv1 loci will provide for the development of new genetic tools in the study of murine lupus, and the in vivo demonstration that Snerv1/Snerv2 À/À yields loss of control of the NEERV gp70 autoantigen provides a framework for improving our understanding of HERV misregulation in human SLE.
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Rowe, H.M., Jakobsson, J., Mesnard, D., Rougemont, J., Reynard, S., Aktas, T., Maillard, P.V., Layard-Liesching, H., Verp, S., Marquis, J., et al. (2010) . T cell isolation kit or the EasySep Mouse CD4 T cell isolation kit (StemCell). For RNA or DNA+RNA isolation, samples in RLT were spun through QIAShredder columns (Qiagen). All samples were stored at -80 prior to RNA isolation. Total Bone Marrow Isolation and Bone-Marrow-Derived Macrophage Generation Bone-marrow-derived macrophages were isolated as described by harvesting femurs and tibias from mice, removing all muscle tissue, and crushing the bones with a mortar and pestle in RPMI to release the marrow. The bone marrow suspension was homogenized by pipetting and then passed through a 70um filter into a 15mL conical. Red blood cells were lysed with ACK lysis buffer and cells were washed twice with RPMI before resuspending in complete RPMI and counting cells. Bone marrow cells were cultured in complete RPMI media supplemented with 50ng/mL recombinant macrophage colony stimulating factor (BioLegend) or with 30% L929-conditioned media. Cells were cultured for 7 days before lysis in RLT buffer for RNA isolation or subsequent chromatin immunoprecipitation. Media was replaced every two days for the duration of culture. Murine Embryonic Fibroblast Generation Pregnant C57BL/6N and C57BL/6J female mice were sacrificed and E14.5 embryos were harvested and processed by first removing heads and livers. The remaining tissue was placed in a petri dish with 2.5mL of 0.05% Trypsin-0.5mM EDTA-PBS and minced with a scissors. The minced tissue was transferred to a 15mL conical, incubated in a 37-degree Celsius shaking water bath for 40min, and dissociated by adding 3mL of DMEM with 10% FBS and pipetting vigorously. The isolated cells were filtered through a 70um filter, resuspended in 15mL of DMEM with 10% FBS, and plated in a 20cm tissue culture dish. The cells were grown to confluency prior to freezing down (considered passage 1). MEFs were grown in 10cm tissue culture plates in 10%FBS in DMEM with 13 penicillin-streptomycin and isolated for RNA at passage 2. Cells were expanded to passage 4 and inactivated with Cesium-137 irradiation for use as ESC feeders. Embryonic Stem Cell Culture C57BL/6N and C57BL/6J embryonic stem cells were obtained from Riken Institute (cell lines AES0143 and AES0144). Cells were cultured by pre-coating the tissue culture vessel with 1% gelatin (Stem Cell Technologies 7903), and then plating the embryonic stem cells along with irradiated C57BL/6J MEFs in maintenance media composed of Knockout DMEM (Gibco), 1x GlutaMax (Gibco), 1x non-essential amino acids (Gibco), 100uM beta-mercaptoethanol, 1x penicillin-streptomycin, and 1000U/mL rmLIF (Millipore ESG1107), supplemented with 20% Knock-Out Serum Replacement (Gibco). Confluent cells were split every 2-3 days for maintenance of the cell line, using 0.25% Trypsin-EDTA (Gibco) to dissociate the cells from the plate. Prior to cell harvest for RNA isolation, cells were plated off of feeders, on tissue culture plates pre-coated with gelatin. Cells were harvested 48 hours later into RLT buffer for RNA isolation.
Oocyte Isolation
All injections and oocyte isolations were performed by the Yale Genome Editing Center. Mature denuded oocytes were isolated as described (Guzeloglu-Kayisli et al., 2012 ) from 6 C57BL/6N and 6 C57BL/6J 3-week-old female mice. Mice were injected intraperitoneally (IP) with 5 IU of pregnant mare serum gonadotropin (PMSG) to induce superovulation. Forty-eight hours later, mice were injected IP with 5 IU of human chorionic gonadotropin (hCG), and mice were sacrificed by cervical dislocation 14hr after this second injection. Ovaries were harvested and the placed into a 60mm petri dish containing pre-warmed M2 medium (Millipore MR-015-D). After dissociating oocytes from the follicles, cumulus cells were detached from the oocytes by addition of 0.3mg/mL hyaluronidase and repeated pipetting of the cumulus-oocyte complexes using a capillary tube microinjection pipette. Oocytes were then washed three times by transferring the cells into new droplets of media and oocytes were counted under the microscope and then transferred into RLT buffer (Qiagen) supplemented with beta-mercaptoethanol. Samples were vortexed and then frozen at -80 degrees Celsius. Immature denuded MI prophase-arrested (germinal vesicle) oocytes were isolated as described (Guzeloglu-Kayisli et al., 2012) from 4 C57BL/6N and 4 C57BL/6J 3-week-old female mice 44hr after IP injection with PMSG and using culture media containing 10uM milrinone to ensure metaphase arrest (Stein and Schindler, 2011) . Flow Cytometry 0.5-1 million splenocytes were plated in a 96-well round-bottom dish and stained with LIVE/DEAD TM Fixable Aqua Dead Cell Stain (ThermoFisher) followed by F c block (clone 2.4G2). To stain for ecotropic and non-ecotropic ERV envelope protein, cells were incubated with hybridoma 83A25 supernatant (Leonard Evans, Rocky Mountain Laboratories) or rat IgG 2A isotype control, followed by mouse anti-rat IgG 2A -biotin and streptavidin-PE-Dazzle594 (BioLegend). Cell surface markers were stained with anti-mouse CD3-APC, B220-BV605, CD4-APC-Cy7, and CD8-FITC (BioLegend). All incubations were performed at a final volume of 30mL for 15-20min at 4 degrees Celsius. Flow cytometry data was analyzed with FlowJo. Reverse Transcription-Quantitative Polymerase Chain Reaction (RT-qPCR) RNA was isolated from total splenocytes or peripheral blood using either the RNeasy Kit or the AllPrep DNA/RNA Kit (Qiagen). cDNA was synthesized using iScriptÔ cDNA Synthesis Kit (Bio-Rad). Quantitative PCR was performed using iTaqÔ Universal SYBR Ò Green Supermix (Bio-Rad) in 10 mL reactions in triplicate using 5-30ng of cDNA per reaction. Primers were used at a final concentration of 0.225 mM and sequences are listed in Table S2 . CD4 + T Cell RNA Library Preparation and Sequencing RNA was isolated from naive and bulk CD4 T cells using the RNeasy Kit and 500ng was used for paired-end library generation with the Illumina TruSeq RNA Library Prep Kit (naive) or the NEB Ultra RNA Library Prep Kit (bulk). Libraries were run on a NextSeq500 to generate 2375 bp or 23150 bp reads.
Oocyte RNA Library Preparation and Sequencing
Oocyte isolations were performed twice to generate biological duplicates, and oocytes were pooled into RLT buffer and stored at À80 degrees Celsius prior to RNA isolation with the RNAeasy Micro Kit (Qiagen). The number of pooled oocytes ranged from 260-310 (immature) and 133-195 (mature) . Due to the low number of cells, sequencing libraries were generated using a modified single cell 96-well plate-based protocol (Haber et al., 2017) . Purified RNA was captured using 2.2X RNAClean XP beads (Agencourt). RNA+beads were incubated on a magnet plate (Alpaqua Magnum FLX) and washed twice with 80% ethanol and air dried. Dried beads were resuspended in 8 mL of Master Mix 1 (2.5 mM 3' RT primer, 2.5 mM dNTPs [Thermo-Fisher] , 1 unit RNAase inhibitor [Takara] ) and incubated at 72 C for 3 minutes, after which the plate was immediately placed on ice for 1 minute to denature the RNA. After this incubation, 14 mL of Master Mix 2 (1.4X Maxima RNase H-minus RT buffer [Thermo-Fisher] [Thermo-Fisher] ) was added to each well. The plate was then incubated at 50 C for 90 minutes followed by 85 C for 5 minutes for reverse transcription. Following reverse transcription, 28 mL of Master Mix 3 (0.4 mM ISPCR primer, 1.8X Kapa HiFi HotStart ReadyMix) was added to each well. cDNA was them amplified for 12 cycles (98 C for 3 minutes followed by 12 cycles of 98 C for 15 seconds, 67 C for 20 seconds, 72 C for 6 minutes followed by 72 C for 5 minutes). Amplified cDNA was purified using 0.7X AMPure XP beads (Agencourt) and washed twice with 70% ethanol and air dried. Dried beads were resuspended in 40 mL of TE and 35 mL of DNA was transferred into a new well. DNA was quantified using a Qubit dsDNA HS kit and DNA was normalized to 0.2 ng/mL. 5 mL of normalized DNA was used to generate RNA-seq libraries using the Nextera XT kit (Illumina). Primers used:
RNA Sequencing Analysis RNA sequencing data from naive CD4 T cells, bulk CD4 T cells, BMDMs, mature and immature oocytes, and public data from SRP018525 (Xue et al., 2013) and SRP059745 (Veselovska et al., 2015) were analyzed as described below.
Cellular Genes
The raw reads of RNA-seq experiments were trimmed of sequencing adaptors and low-quality regions by Btrim (Kong, 2011) . The trimmed reads were mapped to mouse genome (GRCm38; mm10) by Tophat2 (Kim et al., 2013) . After the counts are collected, the differential expression analysis was performed using DEseq2 (Love et al., 2014) , which calculated the fold changes and adjusted p values.
ERV (Mapped to Genome)
The Illumina reads were first trimmed by Btrim (Kong, 2011) to remove sequencing adaptors and low-quality regions. The trimmed reads were mapped to the mouse genome (GRCm38) using BWA-mem (Li and Durbin, 2010) with default parameters. The unmapped reads were filtered out using SAMtools (Li et al., 2009 ) and the mapped reads in SAM format were further processed as the following. The CIGAR field in the SAM file was used to check the number of hard or soft clipping. If the ratio of sum of hard and soft clipping to the length of the read was greater than or equal to 0.02, then the read was discarded. The remaining reads were checked for the field of edit distance compared to the locus reference (NM field). If the ratio of the edit distance to the sequence read length was greater or equal to 0.02, the read was discarded. Finally, the difference between the alignment score (field AS) and the suboptimal alignment score (field XS) was compared. If the difference was less than 5, the read was discarded. The SAM file that contained the mapped reads that pass the filtering steps described above was converted to a BAM file using SAMtools. This BAM file, together with the file that contains the ERV coordinates in the mouse genome (GRCm38) in bed format, was used as input to count the read mapping in each ERV locus by BEDTools (Quinlan and Hall, 2010) . The read counts were normalized by the size factors obtained from the cellular genes of the same sample, calculated using the DESeq2 normalization method. ERV were also mapped to ERV sequences using a reference sequence containing the ERV sequences during the mapping stage, instead of the reference mouse genome.
Analysis of Repetitive Element Enrichment (RepEnrich)
The raw reads of RNA-seq experiments were trimmed of sequencing adaptors and low quality regions by Btrim (Kong, 2011) . The trimmed reads were first mapped to the mouse genome (mm10) using Bowtie (Langmead et al., 2009 ) with options that only allow unique alignments. The reads that mapped to multiple locations were written to separate files. The SAM output file from Bowtie that contained uniquely mapped reads was converted to a BAM file with Samtools and sorted. The sorted BAM file, the file that contained the reads that mapped to multiple locations, and the BED file that contained annotation of target repetitive elements (downloaded from the RepeatMasker track from UCSC genome table browser) were used as input for RepEnrich (Criscione et al., 2014) . RepEnrich first tested the uniquely mapped reads for overlap with annotated repetitive elements. Then, RNA-seq reads mapping to multiple locations were mapped to repetitive element pseudo-genomes that represent all annotated genomic instances of repeat sub-families. If a read mapped to a single repeat sub-family pseudo-genome, it was counted once within that repeat sub-family, whereas reads mapping to multiple repeat sub-family pseudo-genomes were assigned a value equal to the inverse of the number of repeat sub-families aligned. The repeat element sub-family enrichment was equal to the sum of these two numbers rounded to the nearest integer.
Chromatin Immunoprecipitation and Sequencing B6N and B6J BMDMs were crosslinked with 1% formaldehyde (EMS) in 15 cm TC plates for 10 minutes with gentle shaking at room temperature. The reaction was quenched by adding 125 mM final concentration of glycine for another 5 minutes with shaking at room and 129P2/OlaHsd genomes obtained from the Wellcome Sanger Institute's Mouse Genomes Project. The copy number variant discovery programs Sequenza (Favero et al., 2015) and CNVnator (Abyzov et al., 2011) were run on all genomes for chromosome 13 using default settings.
) Mouse Generation Two sets of guide-RNAs were designed in collaboration with the Immunobiology CRISPR Core at Yale University. B6J male mice were mated to superovulated female mice and fertilized embryos were isolated by the CRISPR core. Guide-RNAs were microinjected into the isolated embryos, which were then transferred into pseudopregnant C57BL/6J females. Seventeen pups were obtained and genotyped for CRISPR-mediated deletions.
Genotyping
Ear punches were obtained from mice and gDNA purified using the DNeasy Blood & Tissue Kit (Qiagen). Genotyping primers were designed to flank the sgRNA cut sites and used with TopTac Master Mix Kit (Qiagen) with 5ng of gDNA. To quantitate allele copy number, qPCR was performed as described above using 20ng of gDNA per reaction. Primer sequences are listed in Table S2 . PCR-amplified products were excised, gel purified using the Zymoclean TM Gel DNA Recovery Kit (Zymo Research) and sent for sequencing at the Keck DNA Sequencing Facility at Yale University. Amplified products were also ligated into sequencing vector using the Zero BluntÒ TOPOÒ PCR Cloning Kit (ThermoFisher). Competent DH5a cells were transformed, plated onto LB-agar plates containing kanamycin, and grown overnight at 37 degrees Celsius. Colonies were selected and grown overnight in 3mL of LB-kanamycin and plasmids were isolated using the QIAprep Spin Miniprep Kit (Qiagen) and sequenced.
TaqMan gDNA qPCR A custom TaqMan primer-probe set (ThermoFisher) with a unique binding site within the deleted interval of interest was designed. Along with TaqMan primer-probe sets for mouse transferrin receptor and for Rybp-pseudogene, copy number assays were performed using TaqMan Genotyping Master Mix (ThermoFisher) as 20uL reactions in triplicate using 5-20ng of gDNA per reaction. qPCR data was analyzed using CopyCaller software (ThermoFisher).
growing bacterial cultures overnight from glyercol stocks in 2xYT medium (Sigma) with ampicillin. 250mL cultures were inoculated and grown at 25 degrees Celsius to an OD 600 of $0.6. Cultures were induced with 0.5mM IPTG (American Bioanalytical AB00841) and grown for 16hr at 16 degrees Celsius, and bacteria were pelleted and stored at -20 degrees Celsius. Bacteria were lysed in Lysis Buffer (50mM Tris-HCl (pH 7.4), 100mM NaCl, 0.1% Trition-X-100, 5mM DTT, with cOmplete Protease Inhibitor Cocktail) and transferred to 1.5 ml Bioruptor Plus TPX microtubes. Samples were sonicated for 7 cycles of 30 seconds on/30 seconds off, on high power. After sonication the bacterial lysates were centrifuged for 15 minutes at 14,000rpm at 4 degrees Celsius and the cleared soluble fractions were pooled in a new 15mL tube, to which 2mL of a 50% Glutathione Sepharose 4B (GE) slurry matrix was added. The sample was incubated for 1hr at 4 degrees Celsius and then washed three times with cold PBS. Protein was eluted three times with 1mL of glutathione elution buffer (50mM Tris-HCl, 10mM reduced glutathione, pH 8.0), concentrated by centrifugation (Pierce 88531), and quantitated via colorimetric protein assay (Bio-Rad). Protein fractions were run and visualized on a 10% TGX stain-free gel (Bio-Rad).
DNA Pull-Down Assay Biotinylated-ssDNA and non-labeled ssDNA were annealed via incubation at 95 C for 10 min, and then conjugated to streptavidin Dynabeads (Thermo Fisher Scientific M280) at room temperature for 1hr in DB buffer (20mM Tris-HCl pH8.0, 2M NaCl, 0.5mM EDTA, 0.03% NP-40). 10mg of DNA-conjugated Dynabeads were incubated with 10mg of each of the FLAG-tagged recombinant proteins at RT for 30min in PB buffer (50mM Tris-HCl pH 8.0, 150mM NaCl, 10mM MgCl 2 , 0.5% NP-40, proteinase inhibitor). Beads were then washed three times with PB buffer, eluted, and subjected to immunoblotting, as described above. Oligonucleotide sequences are listed in Table S2 .
Electrophoretic Mobility Shift Assay (EMSA) EMSAs were performed following a published protocol (Steiner and Pfannschmidt, 2009 ) by first annealing AlexaFluor-488-labeled and non-labeled ssDNA to form dsDNA, as described above. Binding reactions (1x binding buffer (Thermo Fisher Scientific), 50 ng/mL sonicated salmon sperm DNA (Invitrogen), 10mM MgCl 2 , 150mM NaCl, 0.5% NP-40) were mixed with 0-10 mg recombinant protein and 0.9 ng/uL of probe and incubated at RT for 30 min. If included, unlabeled competitor probe was added in 10-fold excess to labeled probe. Reactions were run on 6% TBE gels (Invitrogen) without loading dye. Probe migration was detected on a ChemiDoc MP Imaging System (Bio-Rad). Oligonucleotide sequences are listed in Table S2 .
QUANTIFICATION AND STATISTICAL ANALYSIS
In Figures 1A and 1B , mean and standard deviation were plotted, with n = 8 for each group. Figure 1C , Figure 1E , and Figure S1C replicates were obtained from n = 2 mice for each group. Figures 1D, Figure 1F , and Figure S1D , replicates were obtained from BMDM cultures generated from pooled bone marrow from 3 B6N or B6J mice. Figure S1A replicates were obtained from separate BMDM cultures from 3 individual mice. Figure S1B replicates were obtained from individual wells of cultured mES cells. p values in Figure 1 and Figure S1 were calculated for multiple t tests (two-tailed) comparing B6N to B6J for each gene, corrected for the 25 independent hypotheses tested in Figure 1 and Figure S1 using the HolmSidá k method with an alpha value of 0.05 for the entire family of comparisons. Adjusted p values in Figure 1D -E were calculated using DESeq2. In Figure 2B , mean and standard deviation were plotted. P values were calculated for multiple t tests (two-tailed) comparing NEERV to VL30 for each histone mark across each region, corrected for the 9 independent hypotheses tested using the HolmSidá k method with an alpha value of 0.05 for the entire family of comparisons. p values in Figure S2C were calculated using one-way ANOVA with an alpha value of 0.05, 45 degrees of freedom, and F-values of 1.35 (Xmv), 0.207 (Pmv), 0.274 (B-cell MFI), 0.414 (CD4 T-cell MFI), and 0.067 (CD8 T-cell MFI). In Figure 3A , mean and standard deviation were plotted, with n = 4 or n = 8 for each group. p values in Figure 3A were calculated using one-way ANOVA with Sidá k's multiple comparisons test, an F-value of 16.49, 17 degrees of freedom, and an alpha value of 0.05. Genomewide p values for the QTL analysis were calculated by performing 10,000 permutation tests to obtain a genome-wide distribution for the null hypothesis. LOD thresholds for an alpha value of 0.05 were calculated as 3.72 (Xmv), 3.95 (Pmv), 3.90 (B-cell MFI), 3.85 (CD4 T cell MFI), and 3.68 (CD8 T cell MFI). In Figure 4C , mean and standard deviation were plotted, with n = 10 (B6N), n = 10 (B6J), n = 16 (241Rik
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À/À ), n = 18 (241Rik
-/+ ), n = 9 (A À/À ), n = 12 (A +/À ), n = 9 (B À/À ), n = 5 (B +/À ), n = 12 (C À/À ), n = 7 (C +/À ), n = 17 (B6J littermates). In Figure 4E mean and standard deviation were plotted with n = 7 (B6J, 241Rik
) and n=8 (B6N). p values for Figures 4C and 4E were calculated for multiple t tests comparing all genotypes to the B6J WT littermate value for each gene ( Figure 4C ) or comparing the 241Rik
À/À value to that of B6J ( Figure 4E ), corrected for the 33 independent hypotheses tested using the HolmSidá k method with an alpha value of 0.05 for the entire family of comparisons. Adjusted p values in Figure 4D and Figure S4D were calculated using DESeq2. In Figures 6A-6F , mean and standard deviation were plotted. In Figure 6A , n = 14 (Snerv1/Snerv2 À/À xNZB), n = 19 (B6J3NZB). In Figures 6B and 6C , n = 19 (Snerv1/Snerv2 À/À xNZB) and n = 23 (B6J3NZB). In Figures 6D and 6F , n = 16 for each group. p values were calculated for multiple t tests comparing the Snerv À/À -based F1 value to the B6J-based F1 value for each gene, corrected for the 20 independent hypotheses tested using the HolmSidá k method with an alpha value of 0.05 for the entire family of comparisons. Adjusted p values in Figure S6B were calculated using DESeq2. Data was analyzed using GraphPad Prism 7.
DATA AND SOFTWARE AVAILABILITY
The accession number for the data reported in this paper is BioProject: PRJNA498070. The Mendeley dataset is available at https:// doi.org/10.17632/p3bpmhtwwp.1. The mm10 locations of proviral ERV loci are listed in Table S3 . The parsing and mapping algorithms used to analyze mouse proviral ERV expression in RNA-sequencing data can be found as Perl scripts in the Supplementary Information as Data S1 and Data S2.
